Robert Palmér

716 total citations
27 papers, 490 citations indexed

About

Robert Palmér is a scholar working on Epidemiology, Critical Care and Intensive Care Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert Palmér has authored 27 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Critical Care and Intensive Care Medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert Palmér's work include Pneumonia and Respiratory Infections (5 papers), Intensive Care Unit Cognitive Disorders (5 papers) and Cardiac Arrest and Resuscitation (3 papers). Robert Palmér is often cited by papers focused on Pneumonia and Respiratory Infections (5 papers), Intensive Care Unit Cognitive Disorders (5 papers) and Cardiac Arrest and Resuscitation (3 papers). Robert Palmér collaborates with scholars based in United States, Australia and Denmark. Robert Palmér's co-authors include Gerard Notario, María Claudia Pérez, Stuart Atkinson, Todd Busman, Salam Zakko, Ronnie Fass, William D. Chey, Mark H. Gotfried, Andrew Whelton and Lhanoo Gunawardhana and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Clinical Infectious Diseases.

In The Last Decade

Robert Palmér

25 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Palmér United States 14 173 170 114 87 81 27 490
Sukumar Suguna Narasimhulu United States 7 148 0.9× 89 0.5× 52 0.5× 110 1.3× 40 0.5× 18 496
Jiwon Park South Korea 10 42 0.2× 134 0.8× 105 0.9× 49 0.6× 59 0.7× 39 530
Anthony E. Zimmermann United States 10 79 0.5× 86 0.5× 61 0.5× 28 0.3× 296 3.7× 17 615
Diana Altshuler United States 14 127 0.7× 127 0.7× 14 0.1× 95 1.1× 24 0.3× 33 488
William A. Edwards United States 11 75 0.4× 154 0.9× 21 0.2× 72 0.8× 22 0.3× 16 579
B.J.M. Jones United Kingdom 11 40 0.2× 161 0.9× 29 0.3× 133 1.5× 49 0.6× 20 579
Lucia Alfonsi Italy 15 60 0.3× 194 1.1× 42 0.4× 86 1.0× 16 0.2× 24 621
Elisabetta Parenti Italy 14 46 0.3× 81 0.5× 21 0.2× 165 1.9× 94 1.2× 23 525
Hugh Watson Denmark 16 754 4.4× 449 2.6× 84 0.7× 420 4.8× 75 0.9× 47 1.3k
Jian Shou United States 17 225 1.3× 210 1.2× 9 0.1× 101 1.2× 38 0.5× 33 823

Countries citing papers authored by Robert Palmér

Since Specialization
Citations

This map shows the geographic impact of Robert Palmér's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Palmér with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Palmér more than expected).

Fields of papers citing papers by Robert Palmér

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Palmér. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Palmér. The network helps show where Robert Palmér may publish in the future.

Co-authorship network of co-authors of Robert Palmér

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Palmér. A scholar is included among the top collaborators of Robert Palmér based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Palmér. Robert Palmér is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Anstey, Matthew, Robert Palmér, Angela Jacques, et al.. (2023). Intravenous vitamin C for vasoplegia: A double-blinded randomised clinical trial (VALENCIA trial). Journal of Critical Care. 78. 154369–154369. 4 indexed citations
3.
Palmér, Robert, et al.. (2023). Hypercalcaemia of Immobility in Critically Ill Patients: Case Series. Cureus. 15(8). e43070–e43070.
4.
Wood, Alexander, Rashmi Rauniyar, Angela Jacques, et al.. (2022). Oral midodrine does not expedite liberation from protracted vasopressor infusions: A case-control study. Anaesthesia and Intensive Care. 51(1). 20–28. 4 indexed citations
5.
Anstey, Matthew, Rashmi Rauniyar, Natalie Tran, et al.. (2022). Muscle Growth and Anabolism in Intensive Care Survivors (GAINS) trial: a pilot randomised controlled trial. Acute and Critical Care. 37(3). 295–302. 5 indexed citations
6.
Anstey, Matthew, et al.. (2021). Vitamin C and corticosteroids in viral pneumonia. Acute and Critical Care. 36(2). 169–171. 2 indexed citations
7.
Psallidas, Ioannis, Vibeke Backer, Piotr Kuna, et al.. (2020). A Phase 2a, Double-Blind, Placebo-controlled Randomized Trial of Inhaled TLR9 Agonist AZD1419 in Asthma. American Journal of Respiratory and Critical Care Medicine. 203(3). 296–306. 17 indexed citations
8.
Vats, Atul, et al.. (2017). An Airway Risk Assessment Score for Unplanned Extubation in Intensive Care Pediatric Patients*. Pediatric Critical Care Medicine. 18(7). 661–666. 10 indexed citations
9.
Martinez, F. Eduardo, Matthew Anstey, Andrew H. Ford, et al.. (2017). Prophylactic Melatonin for Delirium in Intensive Care (Pro-MEDIC): study protocol for a randomised controlled trial. Trials. 18(1). 4–4. 26 indexed citations
10.
Hays, Allison G., Micaela Iantorno, Michael Schär, et al.. (2017). The influence of febuxostat on coronary artery endothelial dysfunction in patients with coronary artery disease: A phase 4 randomized, placebo-controlled, double-blind, crossover trial. American Heart Journal. 197. 85–93. 11 indexed citations
11.
Gunawardhana, Lhanoo, Henry Punzi, Barbara Hunt, et al.. (2017). Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo‐Controlled Study. Journal of the American Heart Association. 6(11). 53 indexed citations
12.
Naik, Himanshu, Jingtao Wu, Robert Palmér, & Lachy McLean. (2012). The effects of febuxostat on the pharmacokinetic parameters of rosiglitazone, a CYP2C8 substrate. British Journal of Clinical Pharmacology. 74(2). 327–335. 13 indexed citations
13.
Howden, Colin W., Lois Larsen, María Claudia Pérez, Robert Palmér, & Stuart Atkinson. (2009). Clinical trial: efficacy and safety of dexlansoprazole MR 60 and 90 mg in healed erosive oesophagitis – maintenance of healing and symptom relief. Alimentary Pharmacology & Therapeutics. 30(9). 895–907. 34 indexed citations
14.
Fass, Ronnie, William D. Chey, Salam Zakko, et al.. (2009). Clinical trial: the effects of the proton pump inhibitor dexlansoprazole MR on daytime and nighttime heartburn in patients with non‐erosive reflux disease. Alimentary Pharmacology & Therapeutics. 29(12). 1261–1272. 76 indexed citations
15.
Stoller, James K., et al.. (2008). A 61-year-old with bipolar disorder and cognitive impairment: Dementia or polypharmacy?. Cleveland Clinic Journal of Medicine. 75(4). 284–288. 1 indexed citations
17.
20.
Palmér, Robert, et al.. (1983). Nafcillin Resistant Staphylococcus Aureus A Possible Community Origin. Infection Control. 4(3). 153–157. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026